Omicron News and Research

RSS

NIH issues funding opportunities to support the development of new COVID-19 diagnostics

The National Institutes of Health has issued two new funding opportunities for diagnostic test manufacturers to develop the next generation of COVID-19 tests, with a major focus on accessibility.

8 Sep 2022

Biosynthetic proteins show promise as SARS-CoV-2 antivirals targeting spike protein

Researchers developed an αRep series specific to the RBD of the SARS-CoV-2 S, which could easily adapt to work stably against SARS-CoV-2 variants at a low cost.

8 Sep 2022

Study estimates prevalence of long-COVID with variant BA.5 in the U.S.

...

8 Sep 2022

The associations between vaccination status, type, and time since vaccination with lineage identity during the emergence of new SARS-CoV-2 variants

Researchers assessed the association between SARS-CoV-2 strains and patient age, COVID-19 vaccination status, vaccine type, and days elapsed since the most recent vaccination among New York residents.

7 Sep 2022

Researchers identify novel neutralizing monoclonal antibodies against SARS-CoV-2 in vaccinated individuals after wildtype infection

Researchers identified monoclonal antibodies that neutralize SARS-CoV-2 variants.

7 Sep 2022

Study suggests entry of SARS-CoV-2 requires an acidic pH

Researchers carried out real-time single-virion tracking in three dimensions to study the mechanisms and requirements of membrane attachment and fusion of SARS-CoV-2 with the host cell.

6 Sep 2022

Are current COVID-19 vaccines in England effective against severe BA.4 and BA.5 Omicron sub-lineage infections?

Researchers investigated the vaccine efficacy of various COVID-19 vaccines against the BA.2, BA.4, and BA.5 sub-lineages of the SARS-CoV-2 Omicron variant.

5 Sep 2022

Sensitivity of SARS-CoV-2 Omicron BA.2.75 to neutralization by monoclonal antibodies and sera

Researchers assessed the sensitivity of the SARS-CoV-2 Omicron subvariant BA.2.75 spike protein to neutralization by monoclonal antibodies and sera obtained from Swedish individuals.

5 Sep 2022

Regular moderate-intensity exercise may reduce risk of COVID-19 infection and severity

Regular physical activity is linked to a lower risk of COVID-19 infection and severity, including hospital admission and death, finds a pooled data analysis of the available evidence, published online in the British Journal of Sports Medicine.

5 Sep 2022

Study suggests loss of smell and brain inflammation are independent in COVID-19

Researchers assessed the association between neuroinvasion and anosmia observed during COVID-19.

5 Sep 2022

What is the impact of inter-individual heterogeneity on the degree and duration of vaccinal protection against mild and severe COVID-19?

Researchers suggested ways to address heterogeneity in immune responses conferred by COVID-19 vaccines.

5 Sep 2022

Researchers compare the percent excess mortalities due to the zero-COVID-19 policy or the living-with-COVID policy

Researchers compared the percent excess mortalities due to the zero-COVID-19 policy or the living-with-COVID policy.

5 Sep 2022

MHRA approves bivalent COVID-19 booster vaccine made by Pfizer/BioNTech

A second, "bivalent" vaccine has today been approved as a booster by the Medicines and Healthcare products Regulatory Agency (MHRA) after it was found to meet the UK regulator's standards of safety, quality and effectiveness.

3 Sep 2022

Covid-19 study highlights a continued drop in U.S. life expectancy

An updated analysis of American COVID-19 deaths throughout 2021 highlights a continued drop in overall life expectancy as well as persistent disparities by race and ethnicity.

2 Sep 2022

Omicron BA.2.75 not more resistant to antibodies than the currently dominating BA.5 variant, study suggests

In a recent study, researchers from Karolinska Institutet in Sweden, and others, have characterised the new omicron variant BA.2.75, comparing its ability to evade antibodies against current and previous variants.

2 Sep 2022

What is currently known about immune responses to COVID-19 vaccines and cellular immune responses against SARS-CoV-2?

Researchers summarized existing data on the immunogenicity of COVID-19 vaccines and the humoral and cellular immune responses against SARS-CoV-2.

2 Sep 2022

What is the risk of BA.5 infection among persons with documented infection with past variants?

A recent correspondence discussed a study in which researchers assessed the infection risk for the SARS-CoV-2 Omicron BA.5 subvariant in vaccinated people exposed to previous SARS-CoV-2 variants.

2 Sep 2022

The effects of SARS-CoV-2 infection on antibody and B-cell responses to a third dose of mRNA vaccination

Researchers assessed the impact of COVID-19 infection on B-cell and antibody responses to COVID-19 booster vaccination.

2 Sep 2022

Intranasally delivered neutralizing antibody protects against SARS-CoV-2 Omicron and Delta variants

The current study focused on the ability of this nmAb to neutralize Delta, Omicron, and other VOCs, as well as its efficacy when given by the intranasal route in an animal model.

1 Sep 2022

Molecular fate-mapping of antibodies shows effects of antigenic imprinting

In a new study, researchers developed a molecular fate-mapping method for differential detection of antibodies derived from specific B cell clones.

1 Sep 2022

Omicron News and Research

NIH issues funding opportunities to support the development of new COVID-19 diagnostics

Biosynthetic proteins show promise as SARS-CoV-2 antivirals targeting spike protein

Study estimates prevalence of long-COVID with variant BA.5 in the U.S.

The associations between vaccination status, type, and time since vaccination with lineage identity during the emergence of new SARS-CoV-2 variants

Researchers identify novel neutralizing monoclonal antibodies against SARS-CoV-2 in vaccinated individuals after wildtype infection

Study suggests entry of SARS-CoV-2 requires an acidic pH

Are current COVID-19 vaccines in England effective against severe BA.4 and BA.5 Omicron sub-lineage infections?

Sensitivity of SARS-CoV-2 Omicron BA.2.75 to neutralization by monoclonal antibodies and sera

Regular moderate-intensity exercise may reduce risk of COVID-19 infection and severity

Study suggests loss of smell and brain inflammation are independent in COVID-19

What is the impact of inter-individual heterogeneity on the degree and duration of vaccinal protection against mild and severe COVID-19?

Researchers compare the percent excess mortalities due to the zero-COVID-19 policy or the living-with-COVID policy

MHRA approves bivalent COVID-19 booster vaccine made by Pfizer/BioNTech

Covid-19 study highlights a continued drop in U.S. life expectancy

Omicron BA.2.75 not more resistant to antibodies than the currently dominating BA.5 variant, study suggests

What is currently known about immune responses to COVID-19 vaccines and cellular immune responses against SARS-CoV-2?

What is the risk of BA.5 infection among persons with documented infection with past variants?

The effects of SARS-CoV-2 infection on antibody and B-cell responses to a third dose of mRNA vaccination

Intranasally delivered neutralizing antibody protects against SARS-CoV-2 Omicron and Delta variants

Molecular fate-mapping of antibodies shows effects of antigenic imprinting

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News